Showing results (271-280 of 376) with videos related to
Sort By:
Pageof 38
BMC Medical Genetics|April 28, 2010
Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian SpaniardsSergi Veloso, Montserrat Olona, Felipe García, et al.AIDS Care|August 18, 2025
Where did they go? Describing and reengaging people with HIV lost to follow-up in the PISCIS Cohort StudyJorge Palacio-Vieira, Sergio Moreno-Fornés, Yesika Díaz, et al.European Journal of Pharmacology|July 27, 2025
Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIVTania Quesada-López, Alberto Mestres-Arenas, Pere Domingo, et al.HIV Clinical Trials|April 19, 2012
Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patientsJuan Macías, Karin Neukam, Josep Mallolas, et al.The Journal of Infection|December 6, 2011
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosisJuan A Pineda, Karin Neukam, Josep Mallolas, et al.Current HIV Research|July 16, 2009
The changing face of HIV/AIDS in treated patientsJosep M Llibre, Vicenç Falco, Cristina Tural, et al.Current HIV Research|November 16, 2010
Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 StudyJosé A Pérez Molina, Marta Mora Rillo, Ignacio Suárez-Lozano, et al.Plos One|January 27, 2022
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19Julio Collazos, Pere Domingo, Nerio Fernández-Araujo, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 13, 2025
Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trialJose M Miro, Ferran Torres, Christian Manzardo, et al.The Lancet. HIV|August 5, 2024
Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohortJosep M Llibre, Boris Revollo, Jordi Aceiton, et al.Pageof 38